Increase in the number of individuals affected by obesity and cardiovascular diseases is the factor basically augmenting the cholesterol testing products market development.
Cholesterol monitoring devices give information regarding the presence of bad cholesterol in the body, thereby cautioning the individuals about taking measures to reduce the prevalence of cardiovascular diseases (CVDs).
Obese individuals are also recommended to use cholesterol testing kits as they are at the brim of contracting CVDs.
The companies operating in cholesterol testing products market are collaborating with cardiac healthcare institutes to create awareness regarding the importance of testing cholesterol on regular basis with the objective of making cholesterol testing kits reach the higher population base.
A cholesterol testing product measures levels of cholesterol and various other fats in the blood. Those having a family history of high cholesterol or the other risk factors may need testing very often.
Cholesterol is amongst the waxy substances the body needs to produce to build every cell’s outer membrane well. Even though a specific level of cholesterol is necessary, too much of it is likely of building up in the blood vessels and raise risk of stroke, heart disease, and atherosclerosis, i.e. hardening or clogging of the arteries.
However, majority of readily available (and cost-effective) tests measure only total cholesterol, whereas complete understanding of the cholesterol profile needs measurements of HDL, LDL, and triglycerides.
Attribute | Detail |
---|---|
Cholesterol Testing Products Market Drivers |
|
Cholesterol testing products help in determining if the cholesterol is high along with estimation of risk of heart attacks and the other forms of heart diseases and diseases of blood vessels.
A complete cholesterol test helps in measuring levels of cholesterol and the other fats in blood. CDC recommends that this testing should be done every 4-6 years for healthy adults.
A cholesterol testing product provides information regarding risk of development of heart disease. If the test shows that the patient has higher cholesterol, he/she can take proper steps to lower it. This may reduce the probability of heart-related complications in future, thereby cutting down on the number of mortalities as well.
As per the National Institutes of Health, cardiovascular diseases (CVDs) are amongst the leading causes of mortality worldwide. It further states that 20.5 million CVD-related fatalities happen worldwide.
A noticeable rise in the number of individuals suffering from cardiovascular diseases is thus expanding the cholesterol testing products industry size.
Being obese raises the risk of contracting hyperlipidemia (high cholesterol). Obesity is also linked with resistance against insulin, which is one of the components of metabolic syndrome and raises the risk to diabetes. This, in turn, may result in a higher production of triglycerides and LDL, also called bad cholesterol and lesser HDL (good cholesterol).
The cholesterol testing products are equipped with instructions and tools that an individual needs in order to collect the blood sample. Regular usage of these products can help the individuals to take measures toward exercising control over extra cholesterol.
As per the World Heart Federation, nearly 2.3 billion adults and children are living with obesity. It further states that this figure is likely to reach 2.7 billion by 2025.
Continuous increase in the number of obese patients is thus driving the cholesterol testing products market growth.
Attribute | Detail |
---|---|
Leading Region | North America |
As per the latest cholesterol testing products market insights, North America dominates the blood total cholesterol test kit landscape and the scenario is expected to continue during the forecast period.
This is attributed to rise in the incidence of cardiovascular diseases and obesity in the U.S. in September 2020, the CDC notified that frequency of obesity has increased twofold in the since 2010 and the status quo is expected to remain unchanged going forward.
Various companies are entering into collaborations in order to expand their consumer base. For instance, in September 2021, Verv Technologies, in collaboration with Sadbury Company, developed an at-home blood test. The user can thus get the cholesterol tested at home within 15 minutes.
The cholesterol testing products market manufacturers are engaged in launching new products to strengthen their position in the cholesterol measuring device landscape. For instance, in October 2021, Boditech Med introduced ichorma LDL Cholesterol Direct.
It also obtained export licenses for ichorma AST. These are the indicators of averting diseases such as high blood pressure, arteriosclerosis, liver disease, stroke, diabetes, and others.
Athenese-Dx Private Limited, Ngaio Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Biogenix Inc. Pvt. Ltd., CLIAwaived Inc, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Randox, Abcam Limited, Diazyme Laboratories, Inc., and others are some of the key players encompassing the cholesterol testing products market report scope.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
Attribute | Detail |
---|---|
Market Size in 2023 | US$ 21.8 Bn |
Market Forecast (Value) in 2034 | US$ 49.4 Bn |
Growth Rate (CAGR) | 7.8% |
Forecast Period | 2024-2034 |
Historical Data Available for | 2020-2022 |
Quantitative Units | US$ Bn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available Upon Request |
Pricing | Available Upon Request |
It was valued at US$ 21.8 Bn in 2023
It is projected to grow at a CAGR of 7.8% from 2024 to 2034
Growing prevalence of cardiovascular diseases and obesity
Hospitals & clinics segment accounted for the largest share in 2023
North America was the dominant region in 2023
Athenese-Dx Private Limited, Ngaio Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Biogenix Inc. Pvt. Ltd., CLIAwaived Inc, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Randox, Abcam Limited, Diazyme Laboratories, Inc., and Others
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Cholesterol Testing Products Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Cholesterol Testing Products Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Cholesterol Testing Products Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Test Kits
6.3.2. Test Strips
6.3.3. Chemical Analyzers
6.4. Market Attractiveness Analysis, by Product Type
7. Global Cholesterol Testing Products Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Type, 2020-2034
7.3.1. Total Cholesterol Test
7.3.2. High-Density Lipoprotein (HDL) Cholesterol Test
7.3.3. Low-Density Lipoprotein (LDL) Cholesterol Test
7.3.4. Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test
7.4. Market Attractiveness Analysis, by Test Type
8. Global Cholesterol Testing Products Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Clinics
8.3.2. Diagnostic Centers
8.3.3. Others (Research Institutes, etc.)
8.3.4. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Cholesterol Testing Products Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Cholesterol Testing Products Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2020-2034
10.3.1. Test Kits
10.3.2. Test Strips
10.3.3. Chemical Analyzers
10.4. Market Value Forecast, by Test Type, 2020-2034
10.4.1. Total Cholesterol Test
10.4.2. High-Density Lipoprotein (HDL) Cholesterol Test
10.4.3. Low-Density Lipoprotein (LDL) Cholesterol Test
10.4.4. Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Clinics
10.5.2. Diagnostic Centers
10.5.3. Others (Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Test Type
10.7.3. By End-user
10.7.4. By Country
11. Europe Cholesterol Testing Products Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2020-2034
11.3.1. Test Kits
11.3.2. Test Strips
11.3.3. Chemical Analyzers
11.4. Market Value Forecast, by Test Type, 2020-2034
11.4.1. Total Cholesterol Test
11.4.2. High-Density Lipoprotein (HDL) Cholesterol Test
11.4.3. Low-Density Lipoprotein (LDL) Cholesterol Test
11.4.4. Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Clinics
11.5.2. Diagnostic Centers
11.5.3. Others (Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Test Type
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Cholesterol Testing Products Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2020-2034
12.3.1. Test Kits
12.3.2. Test Strips
12.3.3. Chemical Analyzers
12.4. Market Value Forecast, by Test Type, 2020-2034
12.4.1. Total Cholesterol Test
12.4.2. High-Density Lipoprotein (HDL) Cholesterol Test
12.4.3. Low-Density Lipoprotein (LDL) Cholesterol Test
12.4.4. Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Clinics
12.5.2. Diagnostic Centers
12.5.3. Others (Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Test Type
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Cholesterol Testing Products Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2020-2034
13.3.1. Test Kits
13.3.2. Test Strips
13.3.3. Chemical Analyzers
13.4. Market Value Forecast, by Test Type, 2020-2034
13.4.1. Total Cholesterol Test
13.4.2. High-Density Lipoprotein (HDL) Cholesterol Test
13.4.3. Low-Density Lipoprotein (LDL) Cholesterol Test
13.4.4. Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Clinics
13.5.2. Diagnostic Centers
13.5.3. Others (Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Test Type
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Cholesterol Testing Products Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2020-2034
14.3.1. Test Kits
14.3.2. Test Strips
14.3.3. Chemical Analyzers
14.4. Market Value Forecast, by Test Type, 2020-2034
14.4.1. Total Cholesterol Test
14.4.2. High-Density Lipoprotein (HDL) Cholesterol Test
14.4.3. Low-Density Lipoprotein (LDL) Cholesterol Test
14.4.4. Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Clinics
14.5.2. Diagnostic Centers
14.5.3. Others (Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Test Type
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Athenese-Dx Private Limited
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Ngaio Diagnostics
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Abbott Laboratories
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Thermo Fisher Scientific
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Biogenix Inc. Pvt. Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. CLIAwaived Inc
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. F. Hoffmann-La Roche Ltd.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. PerkinElmer, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Randox
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Abcam Limited
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Diazyme Laboratories, Inc.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Others
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 02: Global Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 03: Global Cholesterol Testing Products Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 07: North America Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 08: North America Cholesterol Testing Products Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 11: Europe Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 12: Europe Cholesterol Testing Products Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 15: Asia Pacific Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 16: Asia Pacific Cholesterol Testing Products Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 19: Latin America Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 20: Latin America Cholesterol Testing Products Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 23: Middle East & Africa Cholesterol Testing Products Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 24: Middle East & Africa Cholesterol Testing Products Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Cholesterol Testing Products Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Cholesterol Testing Products Market Revenue (US$ Bn), by Product Type, 2023
Figure 03: Global Cholesterol Testing Products Market Value Share, by Product Type, 2023
Figure 04: Global Cholesterol Testing Products Market Revenue (US$ Bn), by Test Type, 2023
Figure 05: Global Cholesterol Testing Products Market Value Share, by Test Type, 2023
Figure 06: Global Cholesterol Testing Products Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Cholesterol Testing Products Market Value Share, by End-user, 2023
Figure 08: Global Cholesterol Testing Products Market Value Share, by Region, 2023
Figure 09: Global Cholesterol Testing Products Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Cholesterol Testing Products Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 11: Global Cholesterol Testing Products Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Cholesterol Testing Products Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 13: Global Cholesterol Testing Products Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 14: Global Cholesterol Testing Products Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Cholesterol Testing Products Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Cholesterol Testing Products Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Cholesterol Testing Products Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Cholesterol Testing Products Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Cholesterol Testing Products Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Cholesterol Testing Products Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Cholesterol Testing Products Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 22: North America Cholesterol Testing Products Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 23: North America Cholesterol Testing Products Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Cholesterol Testing Products Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Cholesterol Testing Products Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 26: North America Cholesterol Testing Products Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Cholesterol Testing Products Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Cholesterol Testing Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Cholesterol Testing Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Cholesterol Testing Products Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 31: Europe Cholesterol Testing Products Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 32: Europe Cholesterol Testing Products Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Cholesterol Testing Products Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Cholesterol Testing Products Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 35: Europe Cholesterol Testing Products Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Cholesterol Testing Products Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Cholesterol Testing Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Cholesterol Testing Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Cholesterol Testing Products Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 40: Asia Pacific Cholesterol Testing Products Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 41: Asia Pacific Cholesterol Testing Products Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Cholesterol Testing Products Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Cholesterol Testing Products Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 44: Asia Pacific Cholesterol Testing Products Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Cholesterol Testing Products Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Cholesterol Testing Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Cholesterol Testing Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Cholesterol Testing Products Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 49: Latin America Cholesterol Testing Products Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 50: Latin America Cholesterol Testing Products Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Cholesterol Testing Products Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Cholesterol Testing Products Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 53: Latin America Cholesterol Testing Products Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Cholesterol Testing Products Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Cholesterol Testing Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Cholesterol Testing Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Cholesterol Testing Products Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 58: Middle East & Africa Cholesterol Testing Products Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 59: Middle East & Africa Cholesterol Testing Products Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Cholesterol Testing Products Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Cholesterol Testing Products Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 62: Middle East & Africa Cholesterol Testing Products Market Attractiveness Analysis, by End-user, 2024-2034